| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Income - EUR | 0 | 1.821 | 0 | 721 | 0 | 0 | 37.836 | 0 | 0 | 0 |
| Total Expenses - EUR | 2.907 | 3.767 | 1.936 | 2.228 | 1.804 | 1.889 | 11.354 | 17.290 | 0 | 0 |
| Gross Profit/Loss - EUR | -2.907 | -1.946 | -1.936 | -1.507 | -1.804 | -1.889 | 26.482 | -17.290 | 0 | 0 |
| Net Profit/Loss - EUR | -2.907 | -1.946 | -1.936 | -1.507 | -1.804 | -1.889 | 25.246 | -17.290 | 0 | 0 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Medorana S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 6.162 | 5.449 | 5.029 | 4.621 | 4.295 | 3.981 | 0 | 0 | 0 | 0 |
| Current Assets | 14.324 | 12.580 | 10.950 | 9.760 | 7.817 | 6.015 | 36.262 | 0 | 0 | 0 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 12.579 | 10.950 | 9.051 | 7.817 | 6.015 | 5.747 | 0 | 0 | 0 |
| Cash | 14.324 | 1 | 0 | 709 | 0 | 0 | 30.515 | 0 | 0 | 0 |
| Shareholders Funds | 20.175 | 18.023 | 15.782 | 13.986 | 11.910 | 9.796 | 34.824 | 0 | 0 | 0 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 311 | 5 | 197 | 395 | 202 | 201 | 1.438 | 0 | 0 | 0 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Medorana S.r.l.